Clinical Trial Update: A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated safety and immunogenicity of heterologous and homologous prime-boost Ebola vaccine regimens in healthy participants and has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Ad26.ZEBOV
• MVA-BN-Filo

Snippet

Sponsor: Janssen Vaccines & Prevention B.V. | Conditions: Healthy | Phase 1 | Status: COMPLETED